SCHEMBL20642575

SCHEMBL20642575

c1ccc2cc(-c3ccc4nc(-c5ccc6c(c5)CCCC6)ccc4c3)ncc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.43
▸ NPC1 O15118 7/20 0.42
▸ RAB9A P51151 7/20 0.42
▸ ALDH1A1 P00352 7/20 0.40
▸ SMN1; SMN2 Q16637 6/20 0.40
▸ MAPT P10636 3/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ TP53 P04637 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ CYP11B1 P15538 2/20 0.39
▸ CYP11B2 P19099 2/20 0.39
▸ KDM4E B2RXH2 6/20 0.39
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ NFKB1 P19838 2/20 0.39
▸ NFKB2 Q00653 2/20 0.39
▸ RELA Q04206 2/20 0.39
▸ LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18891552 0.88 TDP1 (0.53) TDP1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL24985791 0.84 NPC1 (0.41) TDP1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL18717161 0.82 NPC1 (0.54) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL25463657 0.81 NPC1 (0.48) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL31038194 0.80 NPC1 (0.54) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL20618462 0.77 NPC1 (0.39) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL26040396 0.77 NPC1 (0.51) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL15397046 0.76 NPC1 (0.59) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL731694 0.74 NPC1 (0.62) TDP1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL18845434 0.73 NPC1 (0.45) NPC1RAB9AALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10179804-B2 Melanocortin receptor-specific peptides PALATIN TECHNOLOGIES, INC. (US) 2019-01-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10179804-B2 Melanocortin receptor-specific peptides MC1R, MC3R, MC5R TDP1 4708/4885NPC1 2853/4885RAB9A 307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback